In order to continue supporting customers and partners as best as possible, at ZEISS we are doing everything we can to protect our employees’ health and safety as well as maintain production in our plants and ensure our service operations.
In January, ZEISS set up a dedicated task force. We are closely assessing the latest developments together with government agencies and healthcare authorities on an ongoing basis. Decisions are made daily regarding the most sensible measures for ZEISS to take.
Of course, we will continue to be available for our customers as best we can. Some employees in individual areas are currently working remotely but can still be reached at their usual phone numbers and email addresses.
However, should our customers experience any disruptions in service at some of our sites and sales offices, we can also be contacted on these numbers.
All over the world, the company and its employees are joining the fight against the spread and consequences of the coronavirus pandemic. Read more
17 December 2020
Overall, the ZEISS Group had a good fiscal year 2019/20: revenue totaled 6.297 billion euros (prior year: 6.428 billion euros). With a slight decline of 2% due to the COVID-19 pandemic, revenue almost reached last year's level.
11 December 2020
Carl Zeiss Meditec generated revenue of €1,335.5m in fiscal year 2019/20 (prior year: €1,459.3m), a decline of -8.5% (adjusted for currency effects: -8.7%) year on year. Earnings before interest and taxes (EBIT) decreased to €177.6m (prior year: €264.7m). The EBIT margin was 13.3% (prior year: 18.1%).
10 December 2020
ZEISS and BOSELLO HIGH TECHNOLOGY (BOSELLO) announce that the Italian supplier of solutions for industrial X-ray systems, is now fully part of the ZEISS Group and will operate under the name Carl Zeiss X-ray Technologies Srl.